Raburn M. Mallory

6.5k total citations
33 papers, 863 citations indexed

About

Raburn M. Mallory is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Raburn M. Mallory has authored 33 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Raburn M. Mallory's work include Influenza Virus Research Studies (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Respiratory viral infections research (15 papers). Raburn M. Mallory is often cited by papers focused on Influenza Virus Research Studies (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Respiratory viral infections research (15 papers). Raburn M. Mallory collaborates with scholars based in United States, Japan and Sweden. Raburn M. Mallory's co-authors include Christopher S. Ambrose, Harlan M. Krumholz, Cary P. Gross, Filip Dubovsky, Taff Jones, Hervé Caspard, Xionghua Wu, Tingting Yi, Jing Yu and Therese Takas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Raburn M. Mallory

28 papers receiving 819 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Raburn M. Mallory 435 330 202 118 85 33 863
Patrick Lacor 219 0.5× 319 1.0× 165 0.8× 203 1.7× 53 0.6× 67 1.3k
Muki Shey 358 0.8× 453 1.4× 288 1.4× 73 0.6× 121 1.4× 55 948
Fiona Guerra 398 0.9× 239 0.7× 187 0.9× 55 0.5× 189 2.2× 15 822
Amy C Sherman 475 1.1× 352 1.1× 131 0.6× 106 0.9× 42 0.5× 41 908
Praveen Dhankhar 433 1.0× 223 0.7× 55 0.3× 159 1.3× 68 0.8× 18 859
Saied Ghorbani 178 0.4× 486 1.5× 88 0.4× 138 1.2× 160 1.9× 49 1.0k
Andrew J. Dunning 1.1k 2.5× 366 1.1× 324 1.6× 122 1.0× 220 2.6× 19 1.3k
Victoria Landolfi 956 2.2× 324 1.0× 280 1.4× 116 1.0× 223 2.6× 20 1.2k
Allison August 349 0.8× 239 0.7× 104 0.5× 146 1.2× 21 0.2× 20 717
Ahmed R. Alsuwaidi 248 0.6× 262 0.8× 60 0.3× 39 0.3× 149 1.8× 46 627

Countries citing papers authored by Raburn M. Mallory

Since Specialization
Citations

This map shows the geographic impact of Raburn M. Mallory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raburn M. Mallory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raburn M. Mallory more than expected).

Fields of papers citing papers by Raburn M. Mallory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raburn M. Mallory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raburn M. Mallory. The network helps show where Raburn M. Mallory may publish in the future.

Co-authorship network of co-authors of Raburn M. Mallory

This figure shows the co-authorship network connecting the top 25 collaborators of Raburn M. Mallory. A scholar is included among the top collaborators of Raburn M. Mallory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raburn M. Mallory. Raburn M. Mallory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, Chijioke, Gordon Chau, Elizabeth Clayton, et al.. (2025). Safety and immunogenicity of Omicron protein vaccines in mRNA-vaccinated adolescents: A phase 3, randomised trial. Journal of Infection. 90(2). 106428–106428.
2.
3.
4.
Kotloff, Karen L., R. Scott McClelland, Joyce S. Plested, et al.. (2025). Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study. The Lancet Infectious Diseases. 25(5). 585–594. 5 indexed citations
5.
6.
Toback, Seth, Islam Eltantawy, Raburn M. Mallory, et al.. (2024). Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine. Vaccine. 42(7). 1777–1784. 6 indexed citations
7.
Dunkle, Lisa M., Shabir A. Madhi, Cynthia L. Gay, et al.. (2023). Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Expert Review of Vaccines. 22(1). 501–517. 20 indexed citations
8.
Patel, Nita, Jessica F. Trost, Mimi Guebre‐Xabier, et al.. (2023). XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants. Scientific Reports. 13(1). 19176–19176. 36 indexed citations
9.
Plested, Joyce S., Gordon Chau, Shane Cloney-Clark, et al.. (2023). Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373. Vaccine. 41(29). 4280–4286. 12 indexed citations
10.
Formica, Neil, Raburn M. Mallory, Gary Albert, et al.. (2021). Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLoS Medicine. 18(10). e1003769–e1003769. 64 indexed citations
11.
12.
Mallory, Raburn M., Andrew C. Nyborg, Rubana N. Kalyani, et al.. (2019). A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24–<48 months of age. Vaccine. 38(5). 1001–1008. 9 indexed citations
13.
Mallory, Raburn M., Omar Ali, Therese Takas, et al.. (2017). A phase 1 study to evaluate the safety and pharmacokinetics of MEDI8852, an anti-influenza A monoclonal antibody, in healthy adult volunteers. Biologicals. 50. 81–86. 18 indexed citations
14.
Caspard, Hervé, Kathleen Coelingh, Raburn M. Mallory, & Christopher S. Ambrose. (2016). Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. Vaccine. 34(42). 5066–5072. 33 indexed citations
15.
Matsuoka, Yumiko, Sinthujan Jegaskanda, Theresa Fitzgerald, et al.. (2015). Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). The Journal of Infectious Diseases. 213(6). 922–929. 43 indexed citations
16.
Sheldon, Eric, Robert Jeanfreau, Joseph Sliman, et al.. (2012). Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study*. Influenza and Other Respiratory Viruses. 7(6). 1142–1150. 13 indexed citations
17.
Ambrose, Christopher S., Xionghua Wu, Taff Jones, & Raburn M. Mallory. (2012). The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine. 30(48). 6794–6801. 90 indexed citations
18.
Mallory, Raburn M., Tingting Yi, & Christopher S. Ambrose. (2011). Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6–59 months of age. Vaccine. 29(26). 4322–4327. 32 indexed citations
19.
Mallory, Raburn M., Elissa Malkin, Christopher S. Ambrose, et al.. (2010). Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials. PLoS ONE. 5(10). e13755–e13755. 48 indexed citations
20.
Brown, Bruce K., Josephine H. Cox, Thomas C. VanCott, et al.. (2010). Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults. PLoS ONE. 5(11). e13849–e13849. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Lacor Breakdown of academic impact, for papers by Muki Shey Breakdown of academic impact, for papers by Fiona Guerra Breakdown of academic impact, for papers by Amy C Sherman Breakdown of academic impact, for papers by Praveen Dhankhar Breakdown of academic impact, for papers by Saied Ghorbani Breakdown of academic impact, for papers by Andrew J. Dunning Breakdown of academic impact, for papers by Victoria Landolfi Breakdown of academic impact, for papers by Allison August Breakdown of academic impact, for papers by Ahmed R. Alsuwaidi
Rankless by CCL
2026